Page 74 - Clinical relevance of current materials for cranial implants
P. 74
Chapter 3
72
Table 1: Summary of patient characteristics
Number of patients Gender
254 (100)
52 (20.5)
202 (79.5)
23 (44.2)
24 (46.2)
Male
Age [years; median (IQR)] Comorbidities
130 (51.2) 45.0 (30.0-53.0)
31 (23.8) 42.5 (29.0-54.0)
99 (76.2) 45.0 (32.0-53.0)
15 (65.22) 29.0 (20.0-54.0)
12 (50.0) 46.0 (32.5-61.25)
Cardiovascular disease
Diabetes
Cardiovascular disease and diabetes No relevant comorbidity
37 (14.6) 17 (6.7) 5 (2.0) 195 (76.8)
9 (24.3) 3 (17.6) 1 (20.0) 39 (20)
28 (75.7) 14 (82.4) 4 (80.0) 156 (80)
3 (13.0) 1 (4.3) 1 (4.3) 18 (78.3)
6 (25.0) 1 (4.2) 0 (0.0) 17 (70.8)
Initial diagnosis Cerebrovascular Trauma
Tumor Infection
125 (49.2) 93 (36.6)
25 (9.8)
11 (4.3) 38.5 (33.3-41.6) 133 (83.0-199.5)
26 (20.8)
16 (17.2)
9 (36.0)
1 (9.1)
38.5 (29.2-42.8) 158.5 (90.8-223.5)
99 (79.2)
77 (82.8)
16 (64.0)
10 (90.9) 38.4 (34.3-41.3) 125.5 (82.8-191.25)
13 (56.5)
8 (34.8)
1 (4.3)
1 (4.3) 397.28 (34.8-44.5) 171 (116.0-224.0)
12 (50.0)
5 (20.8)
7 (29.2)
0 (0.0)
32.4 (24.6-42.1) 145.5 (83.3-221.8)
Defect circumference [cm; median (IQR)]
Time interval between decompressive craniectomy and cranioplasty [days; median (IQR)]
Length of cranioplasty [minutes; median (IQR)] Hospitalization [days; median (IQR)]
110 (79.0-140.0)
114 (83.3-142.5)
108.5 (77.25-140.0)
126.0 (104.0-143.0)
83.5 (55.5-131.3)
After decompressive craniectomy
21 (11.8-38.0) 3.0 (2.0-7.0) 112.0 (18.0-553.0) 175.5 (55.0-706.3)
21.5 (11.0-46.8) 3.0 (2.0-19.8) 112.0 (24.3-579.3) 713.5 (328.8-1567.3)
21.0 (12.0-36.25) 3.0 (2.0-5.75) not applicable 97.0 (52.0-406.8)
22.0 (14.0-38.0) 3.0 (2.0-11.0) 618.0 (259.0-884.0) 1229.0 (705.0-1952.0)
20.5 (7.75-64.8) 4.0 (2.0-21.3) 51.5 (24.25-133.0) 424.5 (260.0-1154.3)
After cranioplasty
Time to cranioplasty failure [days; median (IQR)]
Follow-up [days; median (IQR)]
*Reasons for failure were resorption, infection, subcutaneous fluid collections and hemorrhage
N (%)
Failure N* (%)
Success N (%)
Resorption N (%)
Infection N (%)
